212 Pb PSMA
Alternative Names: 212-Pb-PSMA; Lead-212-PSMALatest Information Update: 17 Mar 2024
At a glance
- Originator Orano Med
- Class Antineoplastics; Drug conjugates; Lead radioisotopes; Peptides; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Prostate cancer
Most Recent Events
- 04 Mar 2024 Preclinical trials in Prostate cancer in USA (unspecified route) (Orano Med pipeline, March 2024)